Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.

Abstract

Silymarin and, one of its constituents, silibinin exert strong efficacy against prostate cancer (PCA); however, anticancer efficacy and associated mechanisms of other components of silymarin, which is a mixture of flavonolignans, are largely unknown. Here we have assessed the anticancer efficacy of two pure compounds isosilybin B and isosilybin A, isolated from silymarin, in human prostate carcinoma LNCaP and 22Rv1 cells. Isosilybin B and isosilybin A treatment resulted in growth inhibition and cell death together with a strong G(1) arrest and apoptosis in both the cell lines. In the studies examining changes in cell cycle and apoptosis regulators, isosilybin B and isosilybin A resulted in a decrease in the levels of both cyclins (D1, D3, E and A) and cyclin-dependent kinases (Cdk2, Cdk4 and cell division cycle 25A), but caused an increase in p21, p27 and p53 levels, except in 22Rv1 cells where isosilybin B caused a decrease in p21 protein level. Isosilybin B- and isosilybin A-induced apoptosis was accompanied with an increase in the cleavage of poly (ADP-ribose) polymerase, caspase-9 and caspase-3 and a decrease in survivin levels. Compared with LNCaP and 22Rv1 cells, the antiproliferative and cytotoxic potentials of isosilybin B and isosilybin A were of much lesser magnitude in non-neoplastic human prostate epithelial PWR-1E cells suggesting the transformation-selective effect of these compounds. Together, this study for the first time identified that isosilybin B and isosilybin A, two diastereoisomers isolated from silymarin, have anti-PCA activity that is mediated via cell cycle arrest and apoptosis induction.

• Authors: Gagan Deep, Nicholas H Oberlies, David J Kroll, Rajesh Agarwal
• Journal: Carcinogenesis (Carcinogenesis) Vol. 28 Issue 7 Pg. 1533-42 (Jul 2007) ISSN: 0143-3334 [Print] England
• PMID: 17389612 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Anticarcinogenic Agents
• Antineoplastic Agents, Phytogenic
• BIRC5 protein, human
• Cell Cycle Proteins
• Cyclin-Dependent Kinase Inhibitor Proteins
• Inhibitor of Apoptosis Proteins
• Microtubule-Associated Proteins
• Neoplasm Proteins
• Silymarin
• Survivin
• Cyclin-Dependent Kinases
• Caspases
• isosilybin A

Topics

• Anticarcinogenic Agents (pharmacology)
• Antineoplastic Agents, Phytogenic (pharmacology)
• Apoptosis
• Caspases (metabolism)
• Cell Cycle (drug effects)
• Cell Cycle Proteins (metabolism)
• Cell Line, Tumor
• Cell Proliferation (drug effects)
• Cyclin-Dependent Kinase Inhibitor Proteins (metabolism)
• Cyclin-Dependent Kinases (metabolism)
• Enzyme Activation
• Humans
• Inhibitor of Apoptosis Proteins
• Male
• Microtubule-Associated Proteins (metabolism)
• Neoplasm Proteins (metabolism)
• Prostatic Neoplasms
• Silymarin (analogs & derivatives, chemistry, isolation & purification, pharmacology)
• Stereoisomerism
• Survivin